SEC Form 4 · accession 0001179110-17-008665
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Yung-Cheng Chen
Director
Period of report
Jun 2, 2017
Accepted (ET)
Jun 6, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1,F2 | $3.16 | Jun 2, 2017 | A | 169,988 | A | — | Jun 1, 2027 | Ordinary Shares | 169,988 | 169,988 | D |
Explanation of responses
- F1In ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.
- F2The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise.